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Abstract
Background:  The  Fgf2  gene is expressed in the brain neuroepithelium during embryonic
development and in astroglial cells throughout life. Previous knockout studies suggested that FGF2
plays a role in the proliferation of neural progenitors in the embryonic cerebral cortex. These
studies exclusively used knockout alleles lacking the Fgf2 exon 1. However, the description of
putative alternative exons located downstream from the canonical exon 1 raised the possibility that
alternatively spliced transcripts may compensate for the lack of the canonical exon 1 in the Fgf2 -/
- mice.
Results: We generated and characterized a new line of Fgf2 knockout mice lacking the expression
of exon 3, which is conserved in all Fgf2 transcripts and contains essential heparin and receptor
binding interfaces. The expression of Fgf2 exon 3 was prevented by inserting a transcriptional STOP
cassette in the Fgf2 genomic locus. These mice demonstrate a phenotype in the adult neocortex
characterized by decreased density and number of cortical excitatory neurons and astrocytes,
which is virtually identical to that of the Fgf2 -/- mice lacking exon 1. In addition, we also show that
the Fgf2 exon 3 knockout mice have decreased proliferation of precursors in the adult cerebral
cortex, which had not been previously investigated in the other mutant lines.
Conclusion: The results demonstrate that the phenotype of two completely different Fgf2 KO
mouse lines, lacking exon 1 or exon 3, is remarkably similar. The combined results from these KO
models clearly indicate that FGF2 plays a role in cortical cell genesis during embryonic development
as well as in adulthood. Thus, FGF2 may be required for the maintenance of the pool of adult
cortical progenitor cells.
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Background
FGF2, one of the most potent among the fibroblast
growth factor ligands, is expressed in the neuroepithelium
of the central nervous system ventricular zone (VZ) from
early embryonic development, along with the transmem-
brane FGF receptors FGFR1-FGFR3. FGF2 promotes
growth in the cerebral cortex by increasing the number of
cortical progenitor cells in the VZ [1]. The microinjection
of FGF2 into the ventricles of E15.5 rat embryos increases
cortical volume and the total number as well as density of
glutamatergic neurons and astrocytes in the cortex; how-
ever, FGF2 treatment does not affect cortical thickness or
cortical layer architecture [1]. The in vivo injection of FGF2
does not appear to shorten the cell cycle of progenitor
cells, indicating that it does not act on the kinetics of cell
division. Rather, the increase in total cell number can be
attributed to an increase in the number of progenitor cells
[1].
The expression of FGF2 is steadily down-regulated during
embryonic development [2]. However, FGF2 protein
accumulates postnatally in neurons of the CA2 region of
the hippocampus and the cytoplasm and nucleus of astro-
glial cells throughout the brain [3-5]-.
The analysis of Fgf2 null (Fgf2 -/-) mice demonstrated its
unique role in regulating neurogenesis. Specifically, there
is a 40% decrease in the number of neurons and astrocytes
in the cerebral cortex of Fgf2 -/- mice [1], as well as a
decreased number of dividing progenitors in the VZ [6].
This supports the earlier finding that FGF2 acts on the pro-
genitor population, and when it is missing, the pool of
cortical progenitor cells is significantly decreased. FGF2
may uniquely affect the development of glutamatergic
pyramidal neurons in the cortex [7]. Pyramidal neurons
identified using SMI-32, latexin, and glutamate antibod-
ies were decreased by 38% in the cortex; in contrast, corti-
cal GABAergic interneurons were not significantly
affected. Remarkably, this disruption in excitatory cell
number was most significant in the anterior regions of the
cerebral cortex [7]. The data are consistent with the notion
that FGF2 is important for the development of radial glial
cells, which are neuroepithelial progenitors of the VZ that
give rise to excitatory neurons and astrocytes during neu-
rogenesis [8]. In addition, FGF2 also seems to control cell
migration, since a fraction of the neuronal progenitors
remain in the deeper cortical layers and cannot reach lay-
ers 2 and 3 in Fgf2 -/- mice [9].
Fgf2 is encoded by three exons, exon 1, 2, and 3. In the
original knockout studies, Fgf2 null mice were generated
by deleting exon 1 and immediately upstream sequences
in the Fgf2 gene locus [9-11]-. However, other Fgf2 mRNA
variants have been described that lack the canonical exon
1 and utilize alternative exons (i.e., exon 1b, 1c) that are
located downstream from exon 1 and can be spliced to the
second exon [12]. These studies raise the possibility that
these alternatively spliced transcripts may compensate for
the lack of canonical exon 1 in the Fgf2 -/- mice. To answer
this question, we generated a new recombinant mouse
model that lacks exon 3, an exon that is conserved among
the Fgf2 transcript variants.
Because exon 3 is over 5 kb long, the current strain of Fgf2
knockout mice was generated by inserting a stop codon in
front of this exon. This stop sequence was flanked by Cre
recognition sites, and as such it is amenable to being
excised by Cre recombination, reconstituting the wild
type gene. An important question to be addressed is
whether these mice would show the same or more pro-
found deficits in CNS development, as compared with the
original exon 1 Fgf2 knockout line.
Methods
Generation and characterization of Fgf2 exon 3 knockout 
mice
A targeting vector was constructed containing the
SAβgeolox2 transcriptional STOP cassette (obtained by
Dr. Phillip Soriano, Fred Hutchinson Cancer Research
Center, Seattle) [13] flanked by approximately 5 Kb and 3
Kb of upstream and downstream Fgf2 genomic sequence,
respectively (Fig. 1A). The SAβgeolox2DTA cassette https:/
/www.fhcrc.org/science/labs/soriano/vectors/
SABgeolox2DTA.html contained a splice acceptor site
from Adenovirus (SA), the entire coding sequence for the
βgeo gene (encoding a protein with both β-galactosidase
and neomycin phosphotransferase activity) followed by a
polyadenylation site and flanked by loxP sites. This cas-
sette was inserted by homologous recombination into an
intronic KpnI site, located approximately 1 kb upstream
from the third exon of the Fgf2 gene (Fig. 1A). After elec-
troporation of the targeting vector into E14TG2a embry-
onic stem cells (ES cells), correctly targeted ES cells were
identified by PCR and confirmed by Southern analysis.
Examples of Southern blots used for screening are shown
in Fig. 1B. Correctly targeted ES cells were microinjected
into C57BL/6 strain blastocysts and chimaeric mice were
mated to Black Swiss mice. The Fgf2 heterozygous and
exon 3 knockout mice were maintained by intercrossing
in a Black Swiss background.
To genotype the wild type Fgf2  alleles, the following
primer pairs were used: upstream primer: 5'-TTGGTAC-
CCTGGAATATTTTAGCCC-3'; downstream primer: 5'-
AATAAGTAACCCAGAATATACTGG-3'. These are comple-
mentary to sequences in the intron 2 – 3 at the cassette
insertion site (see Fig. 1A, orange arrowheads). To geno-
type the Fgf2 exon 3 knockout allele, primer pairs comple-
mentary to sequences within the βgeo  gene and
polyadenylation site in the insertion cassette were usedBMC Neuroscience 2008, 9:94 http://www.biomedcentral.com/1471-2202/9/94
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Generation of exon3 knockout by targeted insertion of a transcriptional STOP cassette in the Fgf2 locus Figure 1
Generation of exon3 knockout by targeted insertion of a transcriptional STOP cassette in the Fgf2 locus. A, 
Structure of the targeting vector, the wild type Fgf2 gene and the Fgf2 locus after homologous recombination. Boxes: exons; 
lines: introns; red triangles: LoxP sites; black bars: location of Southern blot probes; double-arrowed lines: size of the corre-
sponding fragments; orange triangles: location of genotyping primers for the wild type allele; green triangles: genotyping prim-
ers for the knockout allele; blue triangles: location of RT-PCR primers to assess the expression of the βgeo product. 
Abbreviations: SA, Splice acceptor from Adenovirus; βgeo, β-galactosidase -Neomycin gene fusion construct; BPA, polyade-
nylation site; PGK DTA, Phosphoglycerate kinase promoter-driven diphtheria toxin gene. B, Southern blot images of DNA 
digests from the correctly targeted ES cells. Black arrows point to the targeted allele, and white arrow to the wild type allele. 
C, RT-PCR with primers specific for the wild type allele (upstream primer in exon 2, downstream primer in exon 3). D, RT-
PCR with primers specific for the knockout allele (located in the βgal construct, blue triangles in A). E, Western blot showing 
absent expression of the FGF2 protein in exon3 KO mice. Wt, wild type mice; ht, heterozygous mice; ko, mice homozygous 
for the exon 3 truncated allele.BMC Neuroscience 2008, 9:94 http://www.biomedcentral.com/1471-2202/9/94
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(upstream primer: 5'-CCTTCTATCGCCTTCTTGACG-3';
downstream primer: 5'-GGTTCCGGATCAGCTTGATTCG-
3') (see Fig. 1A, green arrowheads). The following condi-
tions were used: 94°C for 1 min; 58°C for 1 min and
72°C for 1 min and 30 sec for 34 cycles.
To verify the lack of expression of the Fgf2 exon 3 in the
KO mice, we reverse-transcribed mRNA purified from
brain tissue of wild type mice and Fgf2 exon 3 KO animals
and performed reverse-transcription polymerase chain
reaction (RT-PCR) with an upstream primer in exon 2 and
a downstream primer in exon 3 (upstream primer: 5'-
TACCTTGCTATGAAGGAAGATGG-3'; downstream
primer: 5'-TCAGTGCCACATACCAACTGG-3'; fragment
size: 139 bp; Fig. 1C). To verify the expression of the STOP
cassette, we used primers in the βgeo gene to amplify a
fragment of 346 bp (Fig. 1D). The upstream primer was:
5'-ATCCTCTGCATGGTCAGGTC-3'; the downstream
primer: 5'-CGTGGCCTGATTCATTCC 3' (see Fig. 1A, blue
arrowheads). RNA isolation was performed using Trizol
(Invitrogen, Carlsbad, CA). Brain tissue was obtained
from animals after cervical dislocation and tissue was
homogenized in Trizol. RNA was precipitated using iso-
propanol and washed using 75% ethanol. The RNA pellet
was then re-suspended in RNase-free water. Reverse tran-
scription was performed using the SuperScript III kit (Inv-
itrogen, Carlsbad, CA). PCR was performed on the
resulting cDNA, using the same conditions as those used
for genotyping, described above.
Western blotting
For western blotting, freshly harvested tissue was homog-
enized in 20 mM Tris, 2 mM EDTA, 2 M NaCl, 1% NP40,
PMSF, and FGF2 was extracted according to published
methods [14]. A rabbit polyclonal antibody that recog-
nizes FGF2 epitopes encoded in exons 1 and 2 was used
(1:1000, Santa Cruz Biotechnology, Santa Cruz, CA).
Molecular weights were determined by Precision Plus Pro-
tein standards (Bio-Rad Hercules, CA). Visualization was
by chemiluminescence (Amersham Bioscience, Piscata-
way, NJ).
Immunocytochemistry
Brain samples were obtained by transcardial perfusion
with 4% paraformaldehyde (PFA) in 0.1 M Phosphate
Buffered Solution (PBS), pH 7.4, followed by post-fixa-
tion overnight in 4% PFA and cryprotection in 20%
sucrose. Thirty minutes prior to perfusion, the mice were
injected with 100 mg/kg 2-bromodeoxururidine (BrdU).
Brains were sectioned with a cryostat at 50μm thickness.
For each antibody staining, a series of free-floating sagittal
sections (1 out every 10) were blocked for one hour in a
0.1 M PBS/10% normal goat serum solution, pH 7.4, con-
taining 0.2% Triton-X-100 and 0.1% Tween 20. Immuno-
histochemistry was performed with the following
antibodies: neuronal-specific nuclear protein (NeuN)
(1:500; Chemicon, Temecula, CA), glial fibrillary acidic
protein (GFAP) (1:2000, Dako, Carpinteria, CA), T-box
brain 1 protein (TBR-1) (1:1000, rabbit polyclonal, Dr.
Chris Englund, University of Washington, Seattle, WA)
[15], parvalbumin (1:2500, Sigma-Aldrich, MO). For
BrdU staining, sections were incubated in 30% forma-
mide in 2× SSC for one hour at 65°C, washed in 2× SSC
and incubated for 30 minutes in 2N hydrochloric acid at
37°C. The primary antibody used was BrdU (1:500, Accu-
rate Chemical, Westbury, NY). Sections were then incu-
bated for one hour at room temperature in the
appropriate secondary antibody diluted in 5% normal
goat serum. The secondary antibodies were the following
(all from Molecular Probes, Eugene, OR): Alexa 488-con-
jugated anti-mouse IgG (1:500); Alexa 594-conjugated
anti-rabbit IgG (1:1000); Alexa 488-conjugated anti-rat
IgG (1:1000).
Stereological analyses
Volume and total cell numbers were calculated as
described [16] using the optical fractionator method
using a computer coupled to a Zeiss Axioskope 2 Mot Plus
equipped with a motorized stage, running the StereoIn-
vestigator software (Microbrightfield, Colchester, VT).
Double-immunostaining was visualized by a 594 and 488
nm double exposure filter. Nuclear profiles were counted
in 3-dimensional counting frames (size, 100 × 100 × 5
μm), using a sampling grid of 500 × 500 μm randomly
placed over the drawings of the cerebral cortex. The corti-
cal boundary on each sagittal section was placed to
include the frontal cortex (excluding piriform cortex),
motor and association cortices, somatosensory and asso-
ciation cortices, and visual cortex (excluding retrosplenial
cortex) according to [17]. The upper cortical boundary
was at the pia, and the lower boundary was the white mat-
ter. Hippocampal regions were not included. Counting
frames were placed in the upper portion of the section (1
μm below the surface) to avoid variations due to differen-
tial penetration of antibodies. Between 50 and 150 sam-
pling frames were counted in the cerebral cortex per brain.
Counts were extrapolated to the entire cerebral cortical
volume to obtain total cell number. Total volume was
obtained using the Cavalieri method. The experimental
conditions were not known to the investigator at the time
of quantification to avoid bias in the counting.
Results
Generation and characterization of Fgf2 exon 3 KO mice
The SAβgeolox2DTA DNA cassette, containing a splice
acceptor, preceding the entire coding sequence for the
βgeo gene, which was followed by a polyadenylation site
https://www.fhcrc.org/science/labs/soriano/vectors/
SABgeolox2DTA.html was inserted upstream of exon 3 in
the Fgf2 gene by homologous recombination. In the mod-BMC Neuroscience 2008, 9:94 http://www.biomedcentral.com/1471-2202/9/94
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ified gene locus, βgeo mRNA is expressed instead of exon
3, after which there is premature polyadenylation of the
gene product. The truncated product is thought to be
without function, since many of the receptor binding
interfaces and most of the heparin binding sites are in
exon 3 [18]. With the inclusion of the loxP sites, the Fgf2
gene can be reconstituted via Cre recombination, which
should excise the SAβgeolox2DTA sequence.
The Fgf2 exon 3-deficient mice were born at the normal
Mendelian frequency and displayed no alteration of body
size, fertility, or survival. To assess Fgf2 exon 3 expression,
total RNA was extracted from the brain of 5-month-old
Fgf2 exon 3 KO, wild type and heterozygous mice and
reverse-transcribed into cDNA. RT-PCR analyses were car-
ried out using an upstream primer corresponding to
sequences in exon 2 and a downstream primer corre-
sponding to sequences in exon 3 of the wild type Fgf2
gene. A specific 139-bp amplicon was obtained from Fgf2
wild type and heterozygous mice, but not from their KO
littermates (Fig. 1C), demonstrating the absence of the
exon 3 transcription from the Fgf2 exon 3 KO allele. Con-
versely, the Fgf2  exon 3 KO and heterozygous mice
expressed the βgeo gene in the brain, as assessed by RT-
PCR, while no such expression was detected in the wild
type mice (Fig. 1D). Western blot analysis demonstrated
that the Fgf2 exon 3 KO mice have virtually undetectable
FGF2 protein isoforms as compared to wild type mice
(Fig. 1E).
Phenotypic analyses
In order to compare the phenotype of Fgf2 exon 3 KO
mice with that of Fgf2 exon 1 knockout mice, we carried
out a detailed analysis of the cerebral cortex in young
adult littermate mice (age range, from 2.0 to 5.0 months)
homozygous for the wild type or the Fgf2  exon 3 KO
allele. Cortical neurons and astroglial cells, identified by
NeuN and GFAP immunostaining, respectively (Fig. 2),
were quantified by stereological analyses. Cortical neu-
rons were decreased by 23% and neuronal density was
decreased by 37% in the Fgf2 exon 3 KO mice (Fig. 2A, B;
Table 1). In addition, astroglial cells were decreased by
34%, and astroglial cell density was decreased by 42%
(Fig. 2C, D; Table 1). In contrast, cortical volume was not
significantly changed (wild-type volume, 3.2 ± 0.5 × 1010
μm3, knockout volume 3.0 ± 1.5 × 1010 μm3, p > 0.5). To
assess the number of actively proliferating cells, BrdU was
administered 30 min before perfusion and the incorpora-
tion of the nucleotide in S-phase cells, visualized by
immunostaining, was quantified by stereology in the
whole cerebral cortex. Proliferating cells were decreased
by 29% in the Fgf2 exon 3 KO mice as compared to their
wild type littermates (Table 2).
We next ascertained the role of FGF2 in regulating the pro-
duction of particular subgroups of neurons. In the previ-
ous study examining Fgf2 exon 1 KO mice, it was shown
that the lack of FGF2 caused a 38% decrease in number of
glutamatergic cortical pyramidal neurons as well as in the
size of their cell bodies [7]. In the current study, antibod-
ies to the transcription factor TBR-1 [15] were used to
identify glutamatergic neurons in the cortex (Fig. 2E, F).
Stereological analyses revealed a 19% decrease, which is
less striking than the data from the previous study, but sta-
tistically significant (Table 3). In contrast, the number of
parvalbumin (PV)-expressing GABAergic interneurons
was not significantly affected (Table 3). Based on qualita-
tive analysis, the decrease in pyramidal cells seemed uni-
form between all cortical layers and areas of the cortex.
Discussion
We produced mice with premature termination of the
conserved Fgf2 exon 3 due to insertion of a transcriptional
STOP cassette. Exon 3 contains receptor-binding and
heparin-binding domains, therefore its absence is likely to
result in loss of function. Furthermore, the β-gal-neomycin
gene product is expressed in place of exon 3 in these mice,
resulting in loss of FGF2 immunoreactivity, likely due to
a major conformational change of the protein. Alterna-
tively, the aberrant FGF2-βGEO fusion protein may be
unstable and subjected to degradation. The faint band at
~18 kD in the exon 3 lane (2% of the intensity of the 18
kD band from the wild type mouse) is likely non-specific
because were it to have resulted from read-through of the
truncating stop codon, it would also appear at the 21 kD
and 22 kD positions since all three isoforms are translated
from the same transcripts, and it does not (0% of the
intensity of the wildtype 21 kD and 22 kD bands).
Table 1: Fgf2 exon 3 -/- mice show a decrease in cortical neuron and glial cell populations
Cell number
Wild type Fgf2 -/- % of control
Total NeuN+ cells (106) 1.7 ± 0.04 1.3 ± 0.09* 77
Total GFAP+ cells (106) 1.0 ± 0.08 0.7 ± 0.06* 66
Density NeuN+ cells (103 /mm3) 53 ± 4.8 33 ± 3.3** 63
Density GFAP+ cells (103 /mm3) 33 ± 3.6 19 ± 0.33* 58
Cell number was assessed by stereological analyses. N = 4 per group,*p < 0.05, **p < 0.01 (Student's t-test).BMC Neuroscience 2008, 9:94 http://www.biomedcentral.com/1471-2202/9/94
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This study shows that the lack of Fgf2 exon 3 causes signif-
icant deficits in several major cortical cell populations.
Overall, cortical NeuN+ neuron number was decreased by
23% and that of GFAP+ astrocytes by 34%; one subpopu-
lation of cortical GABAergic interneurons, the PV+
interneurons, was not significantly affected, although we
cannot exclude that a larger sample may reveal a deficit in
this population, as well. This replicates the results
obtained in our previous study of Fgf2  null mice [7],
which were generated by deleting exon 1 in the Fgf2 gene
locus. In that study, NeuN+ cells were decreased by 24%
and glial cells by 38%. Thus, the degree of deficit in these
two cell populations in the two Fgf2 KO models is strik-
ingly similar. The decrease in GFAP+ cells in the adult cor-
tex is also in agreement with the results previously
reported by another group [19]. Also, in agreement with
the present results, all prior studies of Fgf2  KO mice
reported a minimal decrease or no significant change in
total cortical volume. Given the decrease in neuron
number, it is conceivable that some compensatory mech-
anism maintains normal cortical volume; an expansion of
dendritic or synaptic neuropil is a possibility.
Another group reported findings on the cortical pheno-
type of Fgf2 KO mice that are slightly different from those
described above [9]. Dono et al. reported a 25% reduction
in the number of PV+ neurons, but no change in GFAP+
astroglial cells in the cortex of their Fgf2 KO mice lacking
exon 1. Possible reasons for this discrepancy include the
genetic background (C57BL/6J/129/Sv versus Black
Swiss/129/Sv in our mice) and the quantitative methods
used for estimating cell numbers. We examined both total
number and density of cells by stereology using the opti-
cal fractionator and unbiased sampling methods, whereas
Dono et al. assessed cell density, presumably by counting
cells in selected sections.
The decrease in excitatory neurons expressing TBR-1 is less
than what was previously found in the exon 1 KO mice
using immunostaining for the neurotransmitter gluta-
mate. However, TBR-1 + excitatory neurons represent only
a subset of pyramidal cells, those predominantly found in
layer 6 in adult mice. The data suggest that FGF2 may be
relatively more important for the genesis of pyramidal
cells in other cortical layers.
In our prior exon1 Fgf2 KO study [7] the mutants showed
no significant decrease in cortical interneurons, as
assessed by GABA immunostaining. In the current study,
we also found no significant decrease in GABAergic neu-
ron types expressing PV in the cortex. Although the data
tend to confirm the lack of a phenotype among the
GABAergic cell population, we cannot exclude that a non-
PV+ subtype of GABAergic cells is affected by the lack of
FGF2. Recent studies from our laboratory suggest that the
conditional disruption of FGFR1 resulted in a clear loss of
PV+ and somatostatin+ interneurons in the cerebral cortex
[20]. This disparity suggests that other FGF ligands may be
important for the development of cortical GABAergic
cells.
The implications of these results are manifold. First, the
results demonstrate that the phenotype of two completely
different Fgf2 KO mouse lines, lacking exon 1 or exon 3,
is remarkably similar. The combined results from these
KO models clearly indicate that FGF2 plays a role in corti-
cal cell genesis in embryos as well as in adulthood. This is
shown by the similar phenotype in the two lines: a
decrease in total cortical neuron number, due to a deficit
in pyramidal cells as well as in astrocytes, as shown by
NeuN, TBR-1 and GFAP immunostaining. Pyramidal neu-
rons and astrocytes are progeny of radial glial cells, which
are located in the VZ [8]. This is consistent with the previ-
ously demonstrated loss of proliferative progenitors in the
VZ during embryonic development in Fgf2 exon 1 KO
mice [6]. Another cell type that is drastically curtailed in
the Fgf2 KO mice are proliferating stem/progenitor cells in
the adult subventricular zone [21], which are, too, prog-
eny of radial glial cell [22]. It can be hypothesized that this
loss in radial proliferative "units" explains the decrease in
number of excitatory pyramidal neurons, astrocytes and
SVZ neural stem cells.
The current results also show that FGF2 is required for
normal cell proliferation in the mature cortex. In previous
studies on exon 1 KO mice, proliferating cells were
Table 2: Fgf2 exon 3 -/- mice show a decrease in proliferative cell populations
Cell Number
Wild type Fgf2 -/- % of control
Total BrdU+ cell (103) 5.5 ± 0.40 3.9 ± 0.32* 71
Density BrdU+ cells (103 /mm3) 2.3 ± 0.33 1.4 ± 0.090 60
Cell number was assessed by stereological analyses. N = 4 per group, *p < 0.05 (Student's t-test).BMC Neuroscience 2008, 9:94 http://www.biomedcentral.com/1471-2202/9/94
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Immunocytochemical characterization of cellular phenotypes in the cerebral cortex of Fgf2 exon 3 knockout mice Figure 2
Immunocytochemical characterization of cellular phenotypes in the cerebral cortex of Fgf2 exon 3 knockout 
mice. Coronal sections from the parietal regions of the cerebral cortex (above the dorsal hippocampus, approximately 1 mm 
caudal from the hippocampal comissure) of wild type (A, C, F) and Fgf2 exon 3 knockout mice (B, D, F) immunostained for 
Neuronal Antigen (NeuN) (A, B); Glial Fibrillary Acidic Protein (GFAP) counterstained with DAPI (C, D); and TBR-1 (E, F). A 
though D are images of layers 1–3 and E, F are images of layers 5–6. Arrows point to nuclei of immunostained cells. Note the 
decrease in cell density in the knockout. Scale bar, 20 μm.BMC Neuroscience 2008, 9:94 http://www.biomedcentral.com/1471-2202/9/94
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assessed only in embryos [1,6]. The current study indi-
cates for the first time that FGF2 is required for the main-
tenance of the pool of progenitor cells that populate the
cortical parenchyma in adulthood.
Conclusion
This study illustrates a novel way of preventing the expres-
sion of a specific exon of the Fgf2 gene by inserting a tran-
scriptional STOP cassette by homologous recombination
in the Fgf2 genomic locus. Previous research has shown
that there are three putative splice variants of exon 1: 1a,
1b, and 1c [12]. Exon 1a, the canonical exon, was deleted
in the previous Fgf2 KO models [9-11]-. Alternative splic-
ing of exon 1, in principle, could have given rise to differ-
ent products exerting compensatory roles in the absence
of exon 1a in the previously described Fgf2  KO mice.
However, whether these FGF2 variants are actually tran-
scribed into mRNA and protein is unclear. The generation
of an exon 3 KO in the current study sought to verify the
role of FGF2 in development because exon 3 is conserved
in the all known FGF2 variants. The results clearly show
that the phenotype of the Fgf2 exon 3 KO mice show no
greater severity, and that the decrease in cell populations
is very similar to that found in the exon 1 studies. Overall,
the role of FGF2 in regulating cortical development is con-
firmed by removing the conserved exon 3. The relatively
mild phenotype in this Fgf2 mutant may be explained by
compensatory or redundant relationship with other FGF
family genes. Furthermore, this line will allow for future
studies in which the intact Fgf2 gene can be reconstituted
by Cre recombination at selective stages in development
or adulthood.
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